143 related articles for article (PubMed ID: 7151635)
1. Evaluation of the renal and auditory function of neonates treated with amikacin.
Parini R; Rusconi F; Cavanna G; Vigliani E; Cornacchia L; Assael BM
Dev Pharmacol Ther; 1982; 5(1-2):33-46. PubMed ID: 7151635
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycoside-related nephrotoxicity in the premature newborn.
Rajchgot P; Prober CG; Soldin S; Perlman M; Good F; Harding E; Klein J; MacLeod S
Clin Pharmacol Ther; 1984 Mar; 35(3):394-401. PubMed ID: 6365403
[TBL] [Abstract][Full Text] [Related]
3. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
4. Urinary phospholipids excretion in neonates treated with amikacin.
Ibrahim S; Langhendries JP; Bernard A; Tulkens PM
Int J Clin Pharmacol Res; 1994; 14(5-6):149-56. PubMed ID: 7672871
[TBL] [Abstract][Full Text] [Related]
5. Enzymuria determination in children treated with aminoglycosides drugs.
Mohammadi-Karakani A; Asgharzadeh-Haghighi S; Ghazi-Khansari M; Seyed-Ebrahimi A; Ghasemi A; Jabari E
Hum Exp Toxicol; 2008 Dec; 27(12):879-82. PubMed ID: 19273542
[TBL] [Abstract][Full Text] [Related]
6. Once-a-day administration of amikacin in neonates: assessment of nephrotoxicity and ototoxicity.
Langhendries JP; Battisti O; Bertrand JM; François A; Darimont J; Ibrahim S; Tulkens PM; Bernard A; Buchet JP; Scalais E
Dev Pharmacol Ther; 1993; 20(3-4):220-30. PubMed ID: 7828457
[TBL] [Abstract][Full Text] [Related]
7. Ototoxicity and nephrotoxicity of amikacin: an overview of phase II and phase III experience in the United States.
Lane AZ; Wright GE; Blair DC
Am J Med; 1977 Jun; 62(6):911-8. PubMed ID: 868905
[No Abstract] [Full Text] [Related]
8. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.
de Jager P; van Altena R
Int J Tuberc Lung Dis; 2002 Jul; 6(7):622-7. PubMed ID: 12102302
[TBL] [Abstract][Full Text] [Related]
9. Prospective controlled evaluation of auditory function in neonates given netilmicin or amikacin.
Finitzo-Hieber T; McCracken GH; Brown KC
J Pediatr; 1985 Jan; 106(1):129-36. PubMed ID: 3880819
[TBL] [Abstract][Full Text] [Related]
10. Ototoxicity and pharmacokinetically determined dosages of amikacin in granulocytopenic cancer patients.
Danhauer FJ; Fortner CL; Schimpff SC; deJongh CA; Wesley MN; Wiernik PH
Clin Pharm; 1982; 1(6):539-43. PubMed ID: 7185540
[TBL] [Abstract][Full Text] [Related]
11. Proximal tubule damage in patients treated with gentamicin or amikacin.
Wiland P; Szechciński J
Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723
[TBL] [Abstract][Full Text] [Related]
12. [Kinetics of multiple-dose amikacin in the newborn infant].
Olivesi A; Camboulives J; Charrel C; Unal D
Ann Anesthesiol Fr; 1981; 22(2):212-8. PubMed ID: 6115610
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial spectrum, pharmacology, adverse effects, and therapeutic use of amikacin sulfate.
Pien FD; Ho PW
Am J Hosp Pharm; 1981 Jul; 38(7):981-9. PubMed ID: 7020413
[TBL] [Abstract][Full Text] [Related]
14. [Amikacin and kanamycin. Comparative experimental studies on nephrotoxicity].
Züllich B; Sack K
Arzneimittelforschung; 1978; 28(2):271-8. PubMed ID: 580391
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of hospital-acquired urinary infections with amikacin (author's transl)].
Weidner W; Nöske HD; Sziegoleit A; Schröder R; Leidenfrost U
Med Klin; 1979 Jul; 74(27):1071-6. PubMed ID: 470792
[TBL] [Abstract][Full Text] [Related]
16. Influence of intrauterine maturation on the pharmacokinetics of amikacin in the neonatal period.
Assael BM; Parini R; Rusconi F; Cavanna G
Pediatr Res; 1982 Oct; 16(10):810-5. PubMed ID: 7145504
[TBL] [Abstract][Full Text] [Related]
17. Tobramycin and amikacin nephrotoxicity. Value of serum creatinine versus urinary concentration of beta-2-microglobulin.
Gatell JM; SanMiguel JG; Zamora L; Araujo V; Castells C; Moreno A; Jimenez de Anta MT; Marin JL; Elena M; Ballesta A
Nephron; 1985; 41(4):337-43. PubMed ID: 3906418
[TBL] [Abstract][Full Text] [Related]
18. An overview of the safety of isepamicin in adults.
Blum D
J Chemother; 1995 Jun; 7 Suppl 2():87-93. PubMed ID: 8622116
[TBL] [Abstract][Full Text] [Related]
19. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit.
Langhendries JP; Battisti O; Bertrand JM; François A; Kalenga M; Darimont J; Scalais E; Wallemacq P
Biol Neonate; 1998 Nov; 74(5):351-62. PubMed ID: 9742264
[TBL] [Abstract][Full Text] [Related]
20. Ototoxicity of amikacin.
Black RE; Lau WK; Weinstein RJ; Young LS; Hewitt WL
Antimicrob Agents Chemother; 1976 Jun; 9(6):956-61. PubMed ID: 938024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
